Bio-Matrix Announces Construction and Installation of the Class 10,000 Stem Cell Cellular Tissue Processing Laboratory Completed.SAN DIEGO -- Bio-Matrix Scientific Group, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :BMSN BMSN Seaman, Boatswain's Mate Striker (Naval Rating) ), a biotechnology company focused on stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. cryogenics cryogenics: see low-temperature physics. cryogenics Study and use of low-temperature phenomena. The cryogenic temperature range is from −238°F (−150°C) to absolute zero. At low temperatures, matter has unusual properties. and disposable stem cell/tissue transfer instruments, announced today that the construction and installation of its new Stem Cell Class 10,000 Processing Laboratory has been completed. Brian Pockett, Managing Director and COO, stated, "The new class 10,000 laboratory is custom-built to the highest industry specifications. The new laboratory is designed to meet current FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. cGMP (Good Manufacturing Practices) requirements, as well as anticipated more extensive requirements in future. We believe that we can begin the storage of specimens during the first quarter of 2007 after the installation and testing of all related necessary equipment." A Company spokesperson noted that management believes this will be the first commercial adult stem cell Adult stem cells are undifferentiated cells found throughout the body that divide to replenish dying cells and regenerate damaged tissues. Also known as somatic (from Greek Σωματικóς, of the body processing and banking facility in the United States focused on stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young derived from fat tissue. The Company is currently not aware of any other entities commercially processing and banking adipose-derived stem cells at this time. The installation and validation of Bio-Matrix' class 10,000 laboratory marks a major milestone in the Company's goal to offer state-of-the-art and cost-effective stem cell processing and cryopreservation cryopreservation /cryo·pres·er·va·tion/ (-prez?er-va´shun) maintenance of the viability of excised tissue or organs by storing at very low temperatures. cry·o·pres·er·va·tion n. . Availability of these cleanrooms, and their validation to good manufacturing practices (cGMPs), now allows Bio-Matrix to further focus energy on the installation of 'closed' system cellular processing equipment that we expect will not only comply with current FDA cGMP/cGTP requirements, but exceed that currently offered in the industry. Bio-Matrix' new 15,000 sq. ft. state-of-the-art facility, located in the heart of the San Diego biotechnology corridor, will house Bio-Matrix's secure Cryogenic Stem Cell Bank, three Research laboratories, aseptic aseptic /asep·tic/ (-tik) free from infection or septic material. a·sep·tic adj. Of, relating to, or characterized by asepsis. cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology and flow cytometry laboratories. This press release is available on the company's official online Investor Relations HUB at http://www.agoracom.com/IR/Bio-Matrix for investor questions, answers and monitored commentary. Alternatively, investors are able to e-mail all questions and correspondence to BMSN@agoracom.com where they can also request addition to the investor e-mail list to receive all future press releases and updates in real time. About Bio-Matrix Scientific Group, Inc. Bio-Matrix Scientific Group, Inc. (www.BMSNonline.com) is a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market. The Company aligns itself with strategic partners that offer key technologies in biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation, and is building a state-of-the-art facility in San Diego, Calif., to cater to the growing stem cell research segment of the $75 billion biotechnology and medical device industry. DISCLAIMER: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion